Breaking News
November 18, 2018 - Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
November 18, 2018 - Sugar, a ‘sweet’ tool to understand brain injuries
November 18, 2018 - Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
November 18, 2018 - Novel discovery could lead to new cancer, autoimmune disease therapy
November 18, 2018 - AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
November 18, 2018 - Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
November 18, 2018 - New pharmacological agent shows promise for prevention of heart rhythm disorders
November 18, 2018 - All That Social Media May Boost Loneliness, Not Banish It
November 18, 2018 - Scientists shine new light on link between obesity and cancer
November 18, 2018 - Risk factors for cardiovascular disease closely track with changes in diet patterns
November 18, 2018 - Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
November 18, 2018 - Detectable HIV-1 in treated human liver cells found to be inert
November 18, 2018 - Using light to control crucial step in embryonic development
November 18, 2018 - Unusual case of father-to-son HIV transmission reported
November 18, 2018 - FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
November 18, 2018 - Poverty blamed on widening north-south gap in young adult deaths in England
November 18, 2018 - Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
November 18, 2018 - Consensus Statement Issued on Management of Foot, Ankle Gout
November 18, 2018 - Fine particle air pollution is a public health emergency hiding in plain sight
November 18, 2018 - In-hospital mortality higher among patients with drug-resistant infections
November 17, 2018 - Research shines new, explanatory light on link between obesity and cancer
November 17, 2018 - FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings
November 17, 2018 - Tracking Preemies’ Head Size May Yield IQ Clues
November 17, 2018 - Scientists call for unified standards in 3-D genome and epigenetic data
November 17, 2018 - Lab Innovations 2018 has beaten all records by attracting 3,113 attendees
November 17, 2018 - New strategy to hinder emergence of antimicrobial-resistant pathogens
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure
November 17, 2018 - New model of FSHD could be useful to study effectiveness of experimental therapeutics
November 17, 2018 - FDA approves antibacterial drug to treat travelers’ diarrhea
November 17, 2018 - Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers
November 17, 2018 - Largest parasitic worm genetic study hatches novel treatment possibilities
November 17, 2018 - UCLA biologists uncover how head injuries can lead to serious brain disorders
November 17, 2018 - Static and dynamic physical activities offer varying protection against heart disease
November 17, 2018 - Obesity significantly increases risk of Type 2 diabetes and coronary artery disease
November 17, 2018 - Researchers show how proteins interact in hypoxic conditions to facilitate mitochondrial fission
November 17, 2018 - People with rare cancers can benefit from genomic profiling, shows research
November 17, 2018 - NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach
November 17, 2018 - Four-in-one antibody used to fight flu shows promise in mice
November 17, 2018 - New approach allows pathogens to be starved by blocking important enzymes
November 17, 2018 - Higher body mass index could cause depression even without health problems
November 17, 2018 - Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension
November 17, 2018 - FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
November 17, 2018 - ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
November 17, 2018 - UT Southwestern scientists selected to receive 2019 Edith and Peter O’Donnell Awards
November 17, 2018 - New clinical algorithm to help individuals manage type 2 diabetes when fasting during Ramadan
November 17, 2018 - Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway
November 17, 2018 - Heart Disease Leading Cause of Death in Low-Income Counties
November 17, 2018 - Estrogen Levels Test: MedlinePlus Lab Test Information
November 17, 2018 - Research reveals link between immunity, diabetes
November 17, 2018 - Research shows how to achieve improved smoking cessation outcomes within California’s Medicaid population
November 17, 2018 - New study finds less understanding and implementation of patient engagement
November 17, 2018 - New shoe insole technology could help diabetic ulcers heal better while walking
November 17, 2018 - New method to extend cell division and immortalization of avian-derived cells
November 17, 2018 - Australian Academy of Science urges parents to vaccinate children against meningococcal disease
November 17, 2018 - Hot water treatment may help improve inflammation and metabolism in sedentary people
November 17, 2018 - Researchers produce 3D chemical maps of small biological samples
November 17, 2018 - Must Blood Pressure Rise Wth Age? Remote Tribes Hold Clues
November 17, 2018 - Noonan Syndrome
November 17, 2018 - Interventions to delay and prevent type 2 diabetes are underused, researchers say
November 17, 2018 - Hackathon prize winner seeks to remotely monitor patient skin conditions
November 17, 2018 - Research team identifies Ashkenazi Jewish founder mutation for Leigh syndrome
November 17, 2018 - Gene editing could be used to halt kidney disease in patients with Joubert syndrome
November 17, 2018 - Study uncovers link between gut disruption and aging
November 17, 2018 - Teens more likely to pick up smoking after exposure from friends and family
November 17, 2018 - Nicoya designate the Institute for Stem Cell Biology and Regenerative Medicine as the OpenSPR Centre of Excellence
November 17, 2018 - new horizon in dental, oral and craniofacial research
November 17, 2018 - How does poor air quality affect your health?
November 17, 2018 - New device can regulate children’s blood glucose more like natural pancreas
November 17, 2018 - Game-Changers in Western Blotting and Protein Analysis
November 17, 2018 - FDA announces new actions to limit sale of e-cigarettes to youth
November 17, 2018 - Warmer winter temperatures related to higher crime rates
November 17, 2018 - MCO places increasing emphasis on helping people find and access healthy food
November 17, 2018 - Group of students aim to improve malaria diagnosis using old smartphones
November 17, 2018 - Transplantation of feces may protect preterm children from deadly bowel disease
November 17, 2018 - Researchers explore whether low-gluten diets can be recommended for people without allergies
November 17, 2018 - New and better marker for assessing patients after cardiac arrest
November 17, 2018 - For 7-year-old with failing bone marrow, a life-saving transplant | News Center
November 17, 2018 - New first-line treatment for peripheral T-cell lymphoma approved by FDA
November 17, 2018 - Artificial intelligence could be valuable tool to help young victims disclose traumatic testimony
Gene enhancing method is helping discover attainable new drug goals for KRAS-driven cancers

Gene enhancing method is helping discover attainable new drug goals for KRAS-driven cancers

image_pdfDownload PDFimage_print

Cancers pushed by means of mutations within the KRAS gene are a few of the most threatening. For many years, researchers have attempted unsuccessfully to without delay goal mutant KRAS proteins as a method to regard tumors. As an alternative of focused on mutant KRAS itself, researchers at College of California San Diego College of Drugs are actually in search of different genes or molecules that, when inhibited, kill most cancers cells best when KRAS could also be mutated.

The workforce used the CRISPR-Cas9 gene enhancing method to systematically inactivate each gene within the genome of human colorectal most cancers cells with and with out mutant KRAS. They discovered that expansion of KRAS-mutant colorectal most cancers cells in mice used to be lowered by means of roughly 50 % when two genes that encode metabolic enzymes — NADK and KHK — have been additionally inactivated.

The learn about, revealed September 27 in Most cancers Analysis, supplies attainable new drug goals for KRAS-driven cancers.

“We didn’t get those identical effects with most cancers cells grown within the lab — the expansion inhibition we noticed when the NADK and KHK genes have been inactivated best happens in tumors in a mammalian gadget, in a extra real looking microenvironment the place the tumor has to live to tell the tale,” mentioned senior writer Tariq Rana, PhD, professor of pediatrics at UC San Diego College of Drugs and Moores Most cancers Heart. “That means that the metabolic dependencies of tumor cells rising in a laboratory dish might fluctuate dramatically in comparison to the similar cells rising in a dwelling gadget, underscoring attainable boundaries of usual laboratory-based most cancers mobile expansion exams.”

Roughly 20 to 30 % of all human cancers have mutations within the KRAS gene. KRAS mutations happen in most of the maximum deadly and maximum tough to regard cancers, together with lung, pancreatic and colorectal most cancers. KRAS mutant most cancers cells are ready to rewire their metabolism in some way that provides them a expansion benefit in comparison to customary cells.

Rana’s option to treating KRAS-driven cancers — inhibiting different genes or molecules along with KRAS — is named “artificial lethality” since the intervention is best deadly to the mutated cells. In a prior learn about, Rana’s workforce used a library of microRNAs, small items of genetic subject matter, to systematically block protein manufacturing and search for the ones inhibitions which can be artificial deadly together with KRAS mutations.

Of their newest learn about, Rana’s workforce used CRISPR-Cas9 to systematically inactivate genes in two human colorectal most cancers mobile traces — one with customary KRAS and one with a mutant KRAS. They then examined the power of each and every of those mobile traces to develop as tumors in mice. They discovered that inactivating two metabolic enzymes, NADK and KHK, lowered the expansion of KRAS-mutant tumors by means of roughly 50 %, however had no impact on customary KRAS tumors. Additionally they blocked those identical enzymes with commercially to be had small molecule inhibitors and noticed vital relief in tumor expansion in mice best in tumor cells with mutant KRAS.

Rana and workforce additionally known a number of new genes that, when inactivated, had the other impact — they higher KRAS-mutant tumor expansion, however now not the expansion of ordinary KRAS tumors. All these genes are referred to as “tumor suppressors” as a result of they typically stay most cancers mobile expansion in test.

“Some of the sudden findings from our learn about is how acting this sort of genetic display screen without delay in a mammalian microenvironment published now not best new artificial deadly interactions, but additionally new tumor suppressor genes which can be depending on KRAS mutations,” mentioned first writer Edwin Yau, MD, PhD, a hematology/oncology and Most cancers Therapeutics Coaching Program fellow in Rana’s lab.

The sort of new tumor suppressor genes encodes INO80C, a big multi-subunit protein that, amongst different issues, stabilizes the genome. Rana, Yau and co-workers are actually taking steps to hold their findings ahead, with without equal objective of higher working out how KRAS-mutant cancers expand and translating those insights into creating new remedies to prevent them.

Supply:

https://well being.u.s.a..edu/information/releases/Pages/2017-09-27-editing-genes-throughout-colorectal-cancer-cell-genome-uncovers-drug-target.aspx

Tagged with:

About author

Related Articles